Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) Sees Large Volume Increase – Still a Buy?

Recordati Industria Chimica E Farmaceutica S.P.A. (OTCMKTS:RCDTF) saw an uptick in trading volume on Thursday. 750 shares were traded during mid-day trading, an increase of 275% from the previous session’s volume of 200 shares. The stock last traded at $58.79 and had previously closed at $60.00.

Recordati Industria Chimica E Farmaceutica Trading Down 2.0%

The stock’s 50 day moving average is $58.00 and its two-hundred day moving average is $57.77. The company has a market capitalization of $12.13 billion, a PE ratio of 20.97 and a beta of 0.25. The company has a quick ratio of 0.86, a current ratio of 1.26 and a debt-to-equity ratio of 0.79.

Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF) last announced its quarterly earnings results on Wednesday, July 29th. The company reported $0.91 earnings per share for the quarter. The firm had revenue of $810.70 million during the quarter. Recordati Industria Chimica E Farmaceutica had a net margin of 18.38% and a return on equity of 33.73%.

Recordati Industria Chimica E Farmaceutica Company Profile

Recordati Industria Chimica e Farmaceutica S.p.A. is an Italian pharmaceutical company focused on the research, development, manufacture and commercialization of medicines. Its activities are centered on specialty-care and rare-disease treatments, with products addressing areas such as endocrinology, oncology, urology, cardiology, gastroenterology and other specialized medical needs.

The company markets both proprietary and licensed medicines, serving patients through prescription products and therapies for uncommon or underserved conditions.